Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Acta Crystallographica. Section C, Crystal Structure Communications
|
March 15, 1994
(4aR,8R,SR)-8-(p-tolylsulfinyl)-2,3,4,4a,5,6,7,8-octahydro-4a-quinolinol
P D Robinson, D H Hua, H Wang, et al.
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology
|
April 7, 2024
[Geographic environment-related research advances on children's myopia: intraocular and environmental exposure factors and analytical methods]
Q Cui, Y S Xu, J S Gu, et al.
Anti-Cancer Drugs
|
September 7, 1999
Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo
E M Perchellet, J B Ladesich, M J Magill, et al.
Anti-Cancer Drugs
|
July 27, 2000
1,4-Anthraquinone: an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation, and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro
E M Perchellet, M J Magill, X Huang, et al.
Anti-Cancer Drugs
|
November 26, 1999
Triptycenes: a novel synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, induce DNA cleavage and decrease the viability of leukemic cells in the nanomolar range in vitro
E M Perchellet, M J Magill, X Huang, et al.
Carcinogenesis
|
May 1, 1996
Characterization of the antitumor-promoting activity of camptothecin in SENCAR mouse skin
X M Gao, E M Perchellet, A W Davis, et al.
Leukemia Research
|
January 1, 1988
Synthesis and in-vitro cytotoxic activity of phenyl-amino-4-(p-toluenesulfinyl)-trans-1,5-hexadiene
D A Montgomery, J E Cunnick, M J Coulter, et al.
Anti-Cancer Drugs
|
November 15, 2001
Synthetic 1,4-anthracenediones, which block nucleoside transport and induce DNA fragmentation, retain their cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines
M Wu, B Wang, E M Perchellet, et al.
Anti-Cancer Drugs
|
January 7, 1999
Antitumor activity of tricyclic pyrone analogs, a new synthetic class of microtubule de-stabilizing agents, in the murine EMT-6 mammary tumor cell line in vitro
E M Perchellet, J B Ladesich, Y Chen, et al.
International Journal of Cancer
|
May 16, 1996
Camptothecin post-treatments inhibit the biochemical events linked to the tumor-promoting component of carcinogenesis in mouse epidermis in vivo
X M Gao, E M Perchellet, A W Davis, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Acta Crystallographica. Section C, Crystal Structure Communications
|
March 15, 1994
(4aR,8R,SR)-8-(p-tolylsulfinyl)-2,3,4,4a,5,6,7,8-octahydro-4a-quinolinol
P D Robinson, D H Hua, H Wang, et al.
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology
|
April 7, 2024
[Geographic environment-related research advances on children's myopia: intraocular and environmental exposure factors and analytical methods]
Q Cui, Y S Xu, J S Gu, et al.
Anti-Cancer Drugs
|
September 7, 1999
Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo
E M Perchellet, J B Ladesich, M J Magill, et al.
Anti-Cancer Drugs
|
July 27, 2000
1,4-Anthraquinone: an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation, and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro
E M Perchellet, M J Magill, X Huang, et al.
Anti-Cancer Drugs
|
November 26, 1999
Triptycenes: a novel synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, induce DNA cleavage and decrease the viability of leukemic cells in the nanomolar range in vitro
E M Perchellet, M J Magill, X Huang, et al.
Carcinogenesis
|
May 1, 1996
Characterization of the antitumor-promoting activity of camptothecin in SENCAR mouse skin
X M Gao, E M Perchellet, A W Davis, et al.
Leukemia Research
|
January 1, 1988
Synthesis and in-vitro cytotoxic activity of phenyl-amino-4-(p-toluenesulfinyl)-trans-1,5-hexadiene
D A Montgomery, J E Cunnick, M J Coulter, et al.
Anti-Cancer Drugs
|
November 15, 2001
Synthetic 1,4-anthracenediones, which block nucleoside transport and induce DNA fragmentation, retain their cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines
M Wu, B Wang, E M Perchellet, et al.
Anti-Cancer Drugs
|
January 7, 1999
Antitumor activity of tricyclic pyrone analogs, a new synthetic class of microtubule de-stabilizing agents, in the murine EMT-6 mammary tumor cell line in vitro
E M Perchellet, J B Ladesich, Y Chen, et al.
International Journal of Cancer
|
May 16, 1996
Camptothecin post-treatments inhibit the biochemical events linked to the tumor-promoting component of carcinogenesis in mouse epidermis in vivo
X M Gao, E M Perchellet, A W Davis, et al.
Page
of 3